These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 27692306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin.
    Brekelmans MP, Scheres LJ, Bleker SM, Hutten BA, Timmermans A, Büller HR, Middeldorp S.
    Thromb Haemost; 2017 Apr 03; 117(4):809-815. PubMed ID: 28180233
    [Abstract] [Full Text] [Related]

  • 3. Bleeding Risk of Add-On Anti-Platelet Agents to Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation (From 2216 Patients in the DIRECT Registry).
    Sotomi Y, Hirata A, Amiya R, Kobayashi T, Hirayama A, Sakata Y, Higuchi Y.
    Am J Cardiol; 2019 Apr 15; 123(8):1293-1300. PubMed ID: 30717887
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials.
    Loffredo L, Violi F, Perri L.
    Int J Cardiol; 2016 Jun 01; 212():255-8. PubMed ID: 27057930
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
    Hendriks T, McGregor S, Rakesh S, Robinson J, Ho KM, Baker R.
    PLoS One; 2020 Jun 01; 15(6):e0234048. PubMed ID: 32497116
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119).
    Tittl L, Endig S, Marten S, Reitter A, Beyer-Westendorf I, Beyer-Westendorf J.
    Int J Cardiol; 2018 Jul 01; 262():85-91. PubMed ID: 29622509
    [Abstract] [Full Text] [Related]

  • 14. [Not Available].
    Själander S, Själander A.
    Lakartidningen; 2018 Dec 04; 115():. PubMed ID: 30512136
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials.
    Sardar P, Chatterjee S, Lavie CJ, Giri JS, Ghosh J, Mukherjee D, Lip GY.
    Int J Cardiol; 2015 Jan 20; 179():279-87. PubMed ID: 25464465
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antidotes to non-vitamin K oral anticoagulants: necessary or not?
    Proietti M, Lip GY.
    Expert Opin Pharmacother; 2015 Jan 20; 16(11):1573-6. PubMed ID: 26077323
    [Abstract] [Full Text] [Related]

  • 19. Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation.
    Weitz JI, Eikelboom J.
    Thromb Haemost; 2016 Jan 20; 115(2):257-70. PubMed ID: 26466666
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.